It’s not like the chemical was a new discovery. 

It’s just been sitting in a warehouse for the last year. 

And in the middle of all that, there was a little miracle. 

Chemical companies, which were struggling to make a profit, were able to find a way to re-brand the new chemical as a natural and safe one.

 The miracle, however, is that it was not the first time. 

There have been many miracle-stories in recent years. 

But this is the first of its kind. 

This is a miracle-story of a chemical that was once used as a drug to treat a very rare genetic disorder in the early 1990s. 

The chemical was called aplasticin and was found in the soil of the Brazilian Amazon. 

Aplastic is a compound that is often found in plants but has never before been found in living organisms. 

Its chemical name, aplorphine, is a contraction of the Greek word aplos meaning “in or from”. 

It was discovered in the Brazilian rain forest and became a drug that was given to a few people in the 1990s to treat the rare genetic disease known as Carcinoma of the Colorectum and Ovary. 

However, it quickly became apparent that it had very serious side effects, including liver and kidney damage and even death. 

In 1996, the drug was withdrawn due to side effects. 

After a two-year rebranding effort, Aplastic was re-approved for use in the Brazilian Amazon in 2002. 

Now, a company called Bayer has found a way of re-creating the chemical in a way that is safe and effective. 

For the last decade, Bayer has been working with a Brazil national research institute to try to find another chemical to rebrand as Abrinax. 

They’re working on a version of Ablinax that can be made from Agrinax and is the new natural and safe version of Aplorphin that can now be safely used in Brazil. 

Bergman and Brasileiros said that the Aplinax re-rebranding was the most important step in making sure that the natural Abrex is safe for use. 

“Abreix has been approved for use for a very limited time in Brazil, and we are thrilled to be able to rekindle that relationship with Bayer,” said Bergman. 

With this breakthrough, Bayer is hoping to give Abrex to more people. 

We can’t wait to see how it all plays out, Bersimovic said. 

Follow AP Health Writer Amy B Wang on Twitter: @amy_b_wang